A cooperative interaction between LPHN3 and 11q doubles the risk for ADHD.

Mark McIntosh,'s picture
PubMed URL: 
Muenke M
Author List: 
Jain M
Vélez JI
Acosta MT
Palacio LG
Balog J
Roessler E
Pineda D
Londoño AC
Palacio JD
Arbelaez A
Lopera F
Elia J
Hakonarson H
Seitz C
Freitag CM
Palmason H
Meyer J
Romanos M
Walitza S
Hemminger U
Warnke A
Romanos J
Renner T
Jacob C
Lesch KP
Swanson J
Castellanos FX
Bailey-Wilson JE
Arcos-Burgos M
Muenke M
Mol Psychiatry
PubMed ID: 
In previous studies of a genetic isolate, we identified significant linkage of attention deficit hyperactivity disorder (ADHD) to 4q, 5q, 8q, 11q and 17p. The existence of unique large size families linked to multiple regions, and the fact that these families came from an isolated population, we hypothesized that two-locus interaction contributions to ADHD were plausible. Several analytical models converged to show significant interaction between 4q and 11q (P<1 × 10(-8)) and 11q and 17p (P<1 × 10(-6)). As we have identified that common variants of the LPHN3 gene were responsible for the 4q linkage signal, we focused on 4q-11q interaction to determine that single-nucleotide polymorphisms (SNPs) harbored in the LPHN3 gene interact with SNPs spanning the 11q region that contains DRD2 and NCAM1 genes, to double the risk of developing ADHD. This interaction not only explains genetic effects much better than taking each of these loci effects by separated but also differences in brain metabolism as depicted by proton magnetic resonance spectroscopy data and pharmacogenetic response to stimulant medication. These findings not only add information about how high order genetic interactions might be implicated in conferring susceptibility to develop ADHD but also show that future studies of the effects of genetic interactions on ADHD clinical information will help to shape predictive models of individual outcome.
Published Date: 
July, 2012

Bradley L. Schlaggar, M.D., Ph.D., Named President and CEO of Kennedy Krieger Institute

We’re thrilled to welcome Bradley L. Schlaggar, M.D., Ph.D., to the Kennedy Krieger family as our next President and CEO.

Learn more.

Appointments & Referrals



Read inspiring stories, news and updates about the Institute's patient care, research, special education, professional training, and community programs.


Resource Finder


A free resource that provides access to information and support for individuals and families living with developmental disabilities.